CNTF Blocking Peptide (#BLP-NT031) is the original antigen used for immunization during Anti-CNTF Antibody (#ANT-031) generation. The blocking peptide binds and ‘blocks’ Anti-CNTF primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis using Anti-CNTF Antibody on:1. Recombinant human CNTF protein (#C-240), 20ng.
2. Recombinant human Cardiotrophin-1 protein (#C-200), 20ng.
3. Recombinant human LIF protein (#L-200), 20ng.
4. mIL-6, 20 ng.
5. Recombinant human CNTF protein (#C-240), 20ng.
Lanes 1-4. Anti-CNTF Antibody (#ANT-031), (1:200).
Lane 5. Anti-CNTF Antibody, preincubated with CNTF Blocking Peptide (#BLP-NT031).
Antibody specificity is demonstrated in that it specifically recognizes CNTF while it does not reacts with the related cytokines Cardiotrophin-1, LIF and IL-6.
- Expression of Ciliary neurotrophic factor (CNTF) in rat hippoccampusImmunohistochemical staining of rat hippoccampus using Anti-CNTF Antibody (#ANT-031), (1:200). A. CNTF staining (green) reveals astrocyte-profiles (arrows) in the hilus (H) of the dentate gyrus. B. Staining the same section with the astrocyte marker, anti-glial fibrillary acidic protein (red), visualizes astrocytes in the hilus. C. Merge of the two images shows that CNTF is indeed expressed in astrocytes.
- (C)ELSQWTVRSIHDLR, corresponding to amino acid residues 164-177 of human CNTF (Accession P26441).